Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol. - Ottaiano A; Scala S; Normanno N; Napolitano M; Capozzi M; Rachiglio AM; Roma C; Trotta AM; D'Alterio C; Portella L; Romano C; Cassata A; et al. (BMC cancer, 2019)